Drotrecogin alfa (activated) -: Treatment of septic shock

被引：1
|
作者：
Sorbera, LA [1 ]
Martín, L [1 ]
Castañer, RM [1 ]
机构：
[1] Prous Sci, Barcelona 08080, Spain
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 05期
关键词：
D O I：
10.1358/dof.2001.026.05.620122
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：440 / 443
页数：4
相关论文
共 50 条
  • [31] The development of drotrecogin alfa (activated) for the treatment of severe sepsis
    Macias, WL
    Yan, SB
    Grinnell, BW
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 360 - 370
  • [32] Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans
    Bachli, EB
    Vavricka, SR
    Walter, RB
    Leschinger, MI
    Maggiorini, M
    INTENSIVE CARE MEDICINE, 2003, 29 (02) : 337 - 337
  • [33] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Choi, Goda
    de Pont, Anne-Cornelie J. M.
    Schultz, Marcus J.
    CRITICAL CARE, 2006, 10 (04):
  • [34] Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans
    Esther B. Bachli
    Stephan R. Vavricka
    Roland B. Walter
    Monika I. Leschinger
    Marco Maggiorini
    Intensive Care Medicine, 2003, 29 : 337 - 337
  • [35] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Goda Choi
    Anne-Cornélie JM de Pont
    Marcus J Schultz
    Critical Care, 10
  • [36] Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient
    Huston, J. M.
    Eachempati, S. R.
    Rodney, J. R.
    Cayci, C.
    Fusco, D.
    Mathew, M.
    Shou, J.
    Goldstein, M. J.
    Kapur, S.
    Barie, P. S.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (03) : 277 - 280
  • [37] Drotrecogin alfa (activated) treatment of older patients with severe sepsis
    Ely, EW
    Angus, DC
    Williams, MD
    Bates, B
    Qualy, R
    Bernard, GR
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 187 - 195
  • [38] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    Russo, G.
    La Spina, M.
    Disma, N.
    Astuto, M.
    BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 575 - 576
  • [39] The efficacy of drotrecogin alfa (activated) for the treatment of pediatric severe sepsis
    Giroir, B
    Goldstein, B
    Nadel, S
    Wang, DZ
    Levy, H
    Williams, M
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A152 - A152
  • [40] Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer
    G Russo
    M La Spina
    N Disma
    M Astuto
    Bone Marrow Transplantation, 2006, 38 : 575 - 576
12345